Pearls {#Sec1}
======

Osteomas are the most common benign sinonasal lesion with the frontal sinus the most common locationOn sinus MRI, dried secretions show as hyperintense on T1, hypointense on T2, and polyps show hypointense on T1, hyperintense on T2Rhinoscleroma is caused by *Klebsiella rhinoscleromatis* with histopathology showing Mikulicz cells (macrophages containing pathogen) and Russell bodies (plasma cells)

Anatomy {#Sec2}
=======

Nasal FrameworkCartilages: Upper lateral, lower lateral, accessory sesamoid, quadrilateral septalBones: Nasal bones, vomer, perpendicular plate of the ethmoid, maxillary crest, palatine bone, anterior nasal spine of maxillaLateral nasal wall: inferior, middle, superior (sometimes supreme) turbinatesInferior meatus (inferior to inferior turbinate): nasolacrimal duct opening (valve of Hasner)Middle meatus (inferior to middle turbinate): Semilunar hiatus opens to ethmoid infundibulum which receives drainage from maxillary, anterior ethmoid, and frontal sinusesSuperior meatus (anteroinferior to superior turbinate): opening to posterior ethmoid sinusesSphenoethmoidal recess (posterosuperior to superior turbinate): opening to sphenoid sinusesBlood supplyExternal carotid systemFacial arteryAngular artery (located in alar-facial groove): nasal sidewall, tip, and dorsumSuperior labial artery: columella, lateral wallInternal maxillary artery (divides into terminal branches in pterygopalatine fossa)Sphenopalatine artery (enters sphenopalatine foramen on lateral wall at junction of middle turbinate basal lamella and orbital wall)Lateral nasal artery: anterior portion of lateral nasal wallPosterior septal artery: courses over sphenoid face and supplies nasal septumDescending palatine artery (found in greater palatine canal, then enters nasal cavity via incisive foramen): anterior nasal septum and nasal floorInternal Carotid SystemOphthalmic artery terminates into anterior and posterior ethmoid arteriesAnterior ethmoid: Anterior and superior septum, lateral wall, and roof of nasal cavityPosterior ethmoid: Superior turbinate, posterior septumNasal PlexusesKiesselbach's plexus (Little's area): anteroinferior 1/3 of nasal septum; junction of sphenopalatine, greater palatine, anterior ethmoid, and superior labial arteriesWoodruff's plexus: posterior portion of inferior meatus and nasopharynx; junction of posterior nasal, sphenopalatine, and ascending pharyngeal veinsVenous drainageCorresponds to arterial supply"Danger triangle" = area of skin from the corners of the mouth to the bridge of the nose. Veins draining this region are valveless, so skin infection can easily spread retrograde intracranially via angular vein → inferior ophthalmic vein → cavernous sinusLymphaticsAnterior → facial nodes or upper cervical nodesPosterior → retropharyngeal nodesInnervationMuscles of facial expression: CN VIISensory: branches of V1 and V2 for pain, temperature, and touch; CN I at roof of nasal cavity for olfactionParasympathetic (acetylcholine and VIP): superior salivatory nucleus of CN VII →greater superficial petrosal nerve → vidian nerve → sphenopalatine ganglion (synapse) → terminates on blood vessels and glands of the nasal mucosa (induces vasodilation and secretion)Sympathetic (NE): superior cervical ganglion (synapse) → deep petrosal nerve → vidian nerve → terminates on blood vessels and glands of the nasal mucosa (induces vasoconstriction)Paranasal sinusesMaxillary sinusTwo periods of growth: age 3 and age 7--12, coincides with dental growth periodsVolume 15 cm^3^, triangular space completely bound within bone of maxillaOstium drains into middle meatus; accessory ostia present up to 30 % of the timeSeparated from first and second molars by thin layer of bone, can be dehiscent; dental infections can spread to sinus via this route and chronic infection or removal of these teeth can cause an oroantral fistulaEthmoid sinusesReach adult size by age 12, separated into anterior (2--8 cells)/posterior (1--5 cells) by basal lamella of middle turbinate, volume 15 cm^3^Bound by sphenoid face posteriorly, lamina papyracea laterally, middle and superior turbinates medially, and skull base superiorlyKeros classification: can assist in determining risk of violating skull base during FESSI: Cribriform plate 1--3 mm inferior to fovea ethmoidalisII: 4--7 mm inferiorIII: 8--16 mm inferiorLamellae of ethmoid sinus:Uncinate process (forms medial wall of ethmoid infundibulum)Ethmoid bulla (largest anterior ethmoid air cell)Basal lamella of middle turbinate (separates anterior from posterior ethmoid)Lamella of superior turbinateRetrobullar recess = space posterior to ethmoid bulla if bulla not fused to basal lamellaSuprabullar recess = space superior to ethmoid bulla if not fused to skull baseAgger nasi = most anterior ethmoid air cell, pneumatization of lacrimal bone, can block frontal recessSupraorbital ethmoid cell = always posterolateral to true frontal sinus ostium can be confused for frontal sinus septationHaller cell = infraorbital ethmoid cell pneumatizing into the maxillary sinus, can block maxillary sinus ostiumOnodi cell = posterior ethmoid cell located superolateral to sphenoid sinus, may interface with or contain the internal carotid and optic nerveOstiomeatal complex vs. ethmoid infundibulum vs. semilunar hiatusSemilunar hiatus = 2D gap between uncinate and ethmoid bullaInfundibulum = 3D space bounded by uncinate medially, lamina papyracea laterally, and frontal process of maxilla anterosuperiorly = route of drainage for maxillary, anterior ethmoid, and frontal sinusesOstiomeatal complex = includes middle turbinate, uncinate process, semilunar hiatus, ethmoid bulla, and infundibulum = functional drainage pathway for maxillary, anterior ethmoid, and frontal sinusesFrontal sinusPneumatized portion of frontal boneDrains through ostium into frontal recess (bounded by agger nasi anteriorly, ethmoid bulla posteriorly, lamina papyracea laterally, middle turbinate medially, skull base superiorly)Drainage pattern determined by attachment of uncinate process (UP)Attached to lamina papyracea (most common 60--70 %) → drains medial to UPAttached to skull base (5--15 %) or middle turbinate (10--20 %) → drains lateral to UPVisible on X-rays by age 2--6, continues growth into adolescenceTypes of frontal cells:I: Single cell above the agger nasiII: Two or more cells above the agger nasiIII: Single cell extending from the agger nasi superiorly into frontal sinusIV: Cell isolated within frontal sinusSphenoid sinusPneumatization from age 3--18Landmarks: 30° angle relative to nasal floor, 1/3 distance superiorly from choana to skull base, 7 cm from nasal sill, at the same latitude as the roof of the maxillary sinusClosely related to internal carotid, optic nerve, vidian canal, foramen rotundum, cavernous sinus; extremely variable intersinus septum (Fig. [6.1](#Fig1){ref-type="fig"}) Fig. 6.1Sphenoid sinus surrounded by critical structures (seen bilaterally, named from superior to inferior): optic nerve, carotid artery, V2, vidian nerve

Physiology {#Sec3}
==========

HistologyPseudostratified ciliated columnar epithelium covers majority of nasal cavity except nasal vestibule (covered by stratified squamous epithelium)Ciliated columnar cells (9 + 2 microtubules w/dynein arms, beat 10--20×/s), nonciliated columnar cells (microvilli covering surface increase surface area for humidification and warming), basal cells, and goblet cells (produce mucin which traps irritants)Mucin physiologySol layer = deep lubricating layer, produced by microvilliGel layer = superficial viscous layer, produced by goblet cells, traps particlesMucus flows → nasopharynx → secretions swallowedOlfactory epitheliumLocated along upper 1/3 of septum, medial superior/supreme turbinates, roof of nasal cavityGets roughly 15 % of nasal airflowNeural sensory contributions from CN I and small contribution from CN VPseudostratified columnar epithelium with multiple different cell types:Bipolar olfactory neurons (develop from neuroblasts; have cilia that do NOT beat)Sustentacular cells (support cells, have microvilli, protective function)Bowman's glands (produce secretions that bathe olfactory epithelium, required to dissolve odorants prior to nerve stimulation)Basal cells (differentiate into neurons or sustentacular cells)Hyposmia/Anosmia: Caused by damage to nerve itself, inflammation, or obstruction of airflow preventing odorants from reaching the nerveMost common causes are obstructive sinonasal disease/polyps or URI with suspected viral attack on nerve causing inflammation and dysfunctionAlso consider trauma, tumors, iatrogenic surgical damage, chemical irritant or medication-induced damage, endocrine or metabolic disorders (e.g., hypothyroidism), age-related loss of smell (presbyosmia), or early signs of neurologic disease (Alzheimer's or Parkinson's disease)Foster Kennedy Syndrome = unilateral anosmia, optic atrophy, and papilledema due to frontal lobe massesKallman's syndrome = hypogonadotropic hypogonadism and anosmia (failure of hypothalamus to secrete GnRH, several types of inheritance including x-linked and autosomal dominant)Evaluation and management of hyposmia/anosmiaFull history and physical examination including neurologic exam and rigid nasal endoscopy to identify any obvious possible underlying causesTreat patients medically with course of oral steroids, nasal steroid spray, and nasal saline irrigations, then reevaluate in clinic to assess symptoms. Consider MRI for persistent symptoms to rule out masses/tumors.UPSIT (University of Pennsylvania Smell Identification Test) can be used to identify malingering (score \<10/40), for workman's compensation documentation, and for research purposesEvaluation of the nasal airwayMain functions: humidification, warming, filtration, olfaction, alteration of airway resistanceNasal air flow = accounts for 50 % of total airway resistanceInternal nasal valve = most narrow part of nasal airway; bounded by nasal septum, upper lateral cartilage, head of inferior turbinate, and nasal floorEvaluated by Cottle maneuver (subjective improvement in nasal breathing with lateral distraction of the ipsilateral cheek indicates internal valve collapse)Nasal cycle = physiologic variation in vascular flow and sympathetic tone of nasal airway, engorgement of nasal tissue which alternates from one side to the other every 2--6 hObjective measures of nasal airway resistance (commonly used only in research)Rhinomanometry = placement of sensors in the nose or nasopharynx which calculate pressure generated by nasal airflow through the nose before and after nasal decongestant administered. Cannot localize site of obstruction, used in research only.\> 35 % decrease in airway resistance = mucosal congestion\< 35 % decrease in airway resistance = structural abnormalityAcoustic rhinometry = uses sound waves to measure the cross-sectional area at points along the nasal airway. Can identify narrow points in airway but unable to determine whether these narrow areas have any effect on nasal airflow.

Imaging {#Sec4}
=======

Air-fluid level = purulent secretions or blood after trauma (Fig. [6.2](#Fig2){ref-type="fig"}) Fig. 6.2Air-fluid level seen in left maxillary sinus, indicating purulent secretion (and not blood) in this case, as there is no history or sign of traumaDried secretions = hyperintense on T1, hypointense on T2Polyps = hypointense on T1, hyperintense on T2Mycetoma (fungal ball) shows bony thickening of sinus walls on CT, hypointense on T1/T2Allergic fungal sinusitis CT findings include a rim of low density within sinus with central mucin, calcifications, and bony expansion/erosion (Fig. [6.3](#Fig3){ref-type="fig"}) Fig. 6.3Typical AFS imaging showing heterogeneous opacification of the sinuses and hypertelorism (fish eye effect) as the sinus cavity expands outwards, displacing the orbits laterally, to accommodate accumulating polyps and fungal mucinInverting papilloma shows bony thickening at attachment site on CTJuvenile nasal angiofibroma enhances on CT (Fig. [6.4](#Fig4){ref-type="fig"}), hyperintense on MRI with flow voids; Holman-Miller sign = anterior bowing of posterior maxillary sinus wall Fig. 6.4Right maxillary sinus, obstructed by enhancing mass seen within the right nasal cavity and ethmoid region, showing accumulation of post-obstructive secretionsFibrous dysplasia has ground-glass appearance on CT, hypointense on T2 MRI (Fig. [6.5](#Fig5){ref-type="fig"}) Fig. 6.5Classic "ground-glass" appearance of the bone in fibrous dysplasia

Rhinitis {#Sec5}
========

Inflammation of nasal mucosa, affects 25 % of general populationAllergic: IgE-mediated release of immune mediators (histamine, leukotrienes, etc.) from mast cells in response to allergen exposure, type I hypersensitivity reactionSymptoms = nasal congestion, sneezing, eye irritation, thin clear rhinorrheaImmediate phase = within 5 minCross-linking of IgE and degranulation of mast cells releases histamine, leukotrienes, prostaglandin, and platelet activating factor (PAF)Increases vascular permeability, produces main symptoms of rhinorrhea, sneezing, and congestionLate phase = peaks at 6 h, lasts up to 24 hRecurrence of symptoms due to recruitment of inflammatory cells by previously released cytokinesPerennial (i.e., dust mites, insects, dogs, or cats) versus seasonal (i.e., trees, grasses)Diagnosed via history, skin prick testing or serum RASTTreatmentAvoidance of specific allergens, topical antihistamine, anticholinergic, or steroid nasal sprays, oral antihistamines, antileukotrienes, antibody-directed immunomodulators, and subcutaneous or sublingual immunotherapyAtrophic rhinitisSeen after radical nasal surgery with over-resection of inferior and middle turbinate tissue, termed by some "empty nose syndrome"Symptoms = mucosal atrophy, thick foul-smelling crust (ozena)Pathology = transformation of respiratory epithelium into keratinized squamous epithelium, +/− superinfection with *Klebsiella ozoena*Treatment = saline irrigations or gels, topical oil-based lubrication, alternative irrigations such as xylitol or alkalol. Surgical intervention limited to restructuring turbinate morphologyNonallergic Rhinitis with Eosinophilia (NARES) = rhinorrhea, nasal pruritus, and sneezing related to asthma and aspirin sensitivityNo association with IgE-mediated hypersensitivity, negative allergy testsTreatment = Symptomatic relief with nasal steroid spray, antihistaminesVasomotor = excessive parasympathetic tone of nasal mucosaSymptoms similar to allergic rhinitis (with hypersecretion of clear, thin mucus as main symptom) but allergy does not play a roleTriggers include exercise, anxiety, foods (gustatory rhinitis) or changes in temperatureCan also be seen in autonomic dysregulation, commonly seen in elderly patients, or after strokeTreatment = Elimination of triggers and environmental irritants if possible, topical nasal steroid or anticholinergic sprays, or surgery (surface turbinate cautery, partial turbinectomy, or nasal branches of vidian neuronectomy)Medication-inducedAntihypertensives, antidepressants, anti-inflammatory drugsRhinitis medicamentosa = rebound congestion caused by prolonged use of topical alpha adrenergic medicationsTreatment = stop use of topical vasoconstrictors, begin nasal saline +/− nasal steroid spray, may use oral steroid burst for severe nasal obstructionHormone-induced (pregnancy, menstruation, oral contraceptives, hypothyroidism)Estrogen inhibits ACh-esterase → elevated ACh levels → increased parasympathetic toneTreatment = conservative measures including nasal saline, avoid decongestants while pregnantInfectiousUsually viral (most commonly rhinovirus, coronavirus) but can predispose to bacterial superinfection, managed symptomaticallyBacterial colonization:MRSA colonization of anterior nasal cavity commonly found in health care workers, hospitalized patients, treated with Mupirocin ointment to nasal cavityRhinosporidiosis*Rhinosporidium seeberi*, a eukaryotic parasitic pathogenSymptoms = unilateral nasal obstruction, epistaxis, friable polypsPathology = pseudoepitheliomatous hyperplasia, chitinous shellsTreatment = surgical excisionRhinoscleroma*Klebsiella rhinoscleromatis*Symptoms = three stagesCatarrhal (nonspecific crusting)Granulomatous (epistaxis, friable mucosa, nodules throughout upper respiratory tract)Sclerotic (sclerosis and fibrosis)Pathology = Mikulicz cells (macrophages containing pathogen) and Russell bodies (plasma cells)Common in Central America, Africa, IndiaTreatment = long-term antibiotics

Rhinosinusitis {#Sec6}
==============

Fungal SinusitisInvasiveAcuteOccurs in immunocompromised patients (AIDS, malignancy, DM, immunosuppressive meds); fungal invasion into mucosa, soft tissues, and bone, seen as invasion of blood vessels on microscopyPresents as pallor or eschar in nasal cavity or along palate +/− numbness or pain, CT findings of mucosal thickening, sinus opacification (usually maxillary sinus), and infiltration of retroantral fatRapidly progressive (over hours) and can be fatal due to intracranial extension*Mucormycosis*: more common in uncontrolled DM (diabetic ketoacidosis), broad-based ribbon-like nonseptate hyphae with 90° branching*Aspergillus fumigatus*: more common in immunocompromised patients, narrow septate hyphae with branching at acute 45° anglesTreatment = aggressive surgical debridement until healthy bleeding tissue is reached, IV antifungals, treatment of underlying disease process or adjustment of medications to alleviate immunosuppressionChronic GranulomatousFungal invasion of sinonasal tissue with indolent course, produces granulomatous inflammatory response*Aspergillus flavus most common*Treatment = surgical debridement + systemic antifungalsNoninvasiveMycetoma (fungus ball)Isolated sinus opacification, usually maxillary or sphenoid*Aspergillus* common, although fungal cultures can be negativeTreatment = surgical removalAllergic fungal rhinosinusitisBent & Kuhn Criteria for diagnosis: History of Type I HypersensitivityNasal polypsAllergic mucin (contains eosinophils or their breakdown products Charcot-Leyden crystals)Presence of fungal elements on stain or culture (*Aspergillus* or dematiaceous fungi)Characteristic CT findings (unilateral opacification, sinus wall erosion or expansion, heterogeneous density)Lack of invasionTreatment = FESS to open sinuses and remove accumulated thick mucus and polyps, allergy testing and immunotherapy if positive to prevent relapse, often these patients benefit from steroid, whether oral or topicalRhinosinusitisClassificationAcute \< 4 weeksRecurrent ARS requires four or more episodes with complete resolution of symptoms between episodesSubacute 4--12 weeksChronic \> 12 weeksCRSsNP (without nasal polyps) +/− eosinophilia or CRSwNP (with nasal polyps) +/− eosinophiliaAcute exacerbation of CRS = worsening of chronic symptoms with return to baseline after treatment but without complete resolution of symptomsCriteria for diagnosis: inflammation of nose and paranasal sinuses characterized by specific symptomsOlder classification required two major factors (facial pain, nasal congestion, nasal discharge, hyposmia, purulence in nasal cavity) or one major factor and two minor factors (headache, fever, fatigue, cough, ear pain, or pressure)2012 European Position Paper on rhinology classification requires two symptoms---one must be nasal congestion or nasal discharge (other sx = endoscopic signs of edema, purulent discharge, polyps, and mucosal changes on CT)Diagnosis should be supported by endoscopic or CT evidence of diseaseAcute rhinosinusitisEtiologyViral (most commonly rhinovirus, coronavirus) or bacterial (most commonly *Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis*)Pathophysiology: Viral infection causes upregulation of inflammatory factors and leads to mucus hypersecretion and mucosal edema. In combination with a variety of predisposing factors (e.g., trauma, anatomic obstruction, ciliary dysmotility, immune factors), this can lead to mucus stasis or obstruction of sinus outflow tracts → provides ideal setting for bacterial growthTreatmentSupportive care and reassurance for mild symptomsAntibiotics for severe symptoms (first line = amoxicillin or cephalosporins; if symptoms do not improve then second line = amoxicillin-clavulanate or respiratory quinolones), culture-directed, if possibleNasal saline irrigationsIntranasal steroids, short course oral steroids (can improve facial pain, headache)Oral analgesics and mucolyticsComplications:Orbital complications---described in increasing severity by Chandler's classification Preseptal cellulitisPeriorbital soft tissue erythema/edemaNo chemosis, vision changes, or dysmotilityTx = oral antibioticsOrbital cellulitisInflammation within orbitPresence of chemosis, proptosis, limited mobility, and/or vision changesTx = IV antibiotics + functional endoscopic sinus surgery (FESS)Subperiosteal abscessSimilar to orbital cellulitis WITH presence of pus between orbital periosteum and boneTx = IV antibiotics + FESS and surgical drainage of abscess. Can consider antibiotics alone for a small abscess in a clinically stable patient \<2--4 years old without vision change, but should monitor closely with immediate surgical intervention available for signs of progressionOrbital abscessPus located within the orbitSevere proptosis and ophthalmoplegiaTx = IV antibiotics + FESS and surgical drainageCavernous sinus thrombosisStructures which pass through cavernous sinus: CN III, IV, V1, V2, VI, internal carotid artery, and multiple venous channelsSymptoms = ophthalmoplagia, headache, periorbital sensory loss, papilledema/proptosis/periorbital edema/vision loss (from venous congestion); CN VI first to show effectsTx = IV antibiotics + FESS (+/− anti-thrombotics, controversial)Infections from sinuses spread directly or via hematogenous spread, most commonly from ethmoidsAlways obtain ophthalmology consultation and document visual acuity, extent of proptosis, measurement of pressure, and eye movements (important to perform forced duction testing to examine if limit to EOM is due to pain or pathology)General indications for OR = change in or loss of vision or EOM, or any other cranial nerve deficitIntracranial complicationsEpidural, subdural, or intracranial abscess (Tx = IV antibiotics +/− neurosurgical drainage)Meningitis = headache, altered mental status, high fever, neck stiffness (Tx = first obtain head CT, LP if no intracranial mass seen on CT, IV antibiotics)Infection spreads via direct extension, along olfactory nerve sheath, or hematogenously (foramina of Breschet = venous perforators connecting intracranial and extracranial vascular supply), most common from frontal sinusPott's Puffy TumorOsteomyelitis of anterior table of frontal sinusInfection transmitted via diploic veins → swelling of adjacent forehead soft tissueTx = IV antibiotics, FESS and surgical debridement of sequestered boneMucoceleExpansile collection of secretions trapped within an obstructed sinusCT = sinus expansion and bony erosion; MRI T2 = hyperintenseTx = FESS, with open procedures for inaccessible lesionsSuperior Orbital Fissure SyndromeDue to infectious spread to or trauma involving superior orbital fissureStructures included: III, IV, V1, VI, ophthalmic vein, and sympathetic fibersSymptoms = ophthalmoplegia, ptosis, proptosis, ipsilateral forehead paresthesia, and fixed dilated pupilOrbital Apex SyndromeSymptoms of superior orbital fissure syndrome + involvement of CN II (vision change or blindness)Chronic Rhinosinusitis (CRS)Contributing factorsMicrobial factorsBiofilms = aggregate of bacteria encased in self-produced polysaccharide matrix which confers antibiotic resistanceSuperantigens = bacterial exotoxins which trigger a much larger downstream T-cell activation than traditional exotoxins without requiring antigen specificityEnvironmental factors (smoking, pollution, allergens)Anatomic factors (septal deviation, concha bullosa, infraorbital cells, scarring, etc.)Mucociliary dysfunctionPrimary ciliary dyskinesia (PCD) = AR defect in dynein arms of cilia of respiratory tract and reproductive system → URIs, otitis media, infertilityKartagener's syndrome = PCD + situs inversus and bronchiectasisCystic fibrosis = AR mutation in CFTR gene which impairs chloride transport → thick mucus prevents clearing of bacteria (diagnosed with sweat chloride test)Immunologic factorsAllergyNasal mucosal congestion which occurs in allergic rhinitis → obstruction of sinus ostia → impaired sinus ventilation → mucus retention and infectionSamter's TriadSinonasal polyposis, asthma, and aspirin sensitivityASA ingestion → inhibits cyclo-oxygenase metabolism of arachidonic acid → stimulates 5-lipo-oxygenase and production of leukotrienes → asthma and allergy effectsPathophysiology is complex and multifactorial, involving any of the above listed factors which contribute to mucosal inflammationTreatment3--6 weeks treatment with antibiotics (amoxicillin-clavulanate, respiratory quinolones, second-generation cephalosporins, etc.)Topical nasal steroid spray, oral steroid taper, nasal saline irrigation, mucolyticsTreatment of any underlying allergySurgery for patients refractory to medical management, mucoceles, or signs of orbital/intracranial complications

Epistaxis {#Sec7}
=========

Anterior source 90 % of the timeEtiologiesLocalDigital trauma, facial traumaInflammation or infectionSeptal deviation or perforation (aberrant airflow causes drying of tissues which become friable)Dry nasal environment (CPAP, decongestants, dry climates)Foreign bodies (local irritation or secondary to attempts at removal)Tumors (secondary to erosion into vessels)Carotid aneurysm (rare, usually a late complication occurring several years after trauma accompanied by monocular blindness)SystemicTB, Wegener's granulomatosis (respiratory tract granulomas, vasculitis, and glomerulonephritis), sarcoidosis (noncaseating granulomas), syphilisSymptoms = crusting, friable mucosa, septal perforationOsler Weber Rendu Disease (Hereditary hemorrhagic telangiectasia)Autosomal dominant, numerous small vascular malformations of the skin and mucosal linings of the aerodigestive tract, AVMs of larger organs (lung, liver, brain)Epistaxis and GI bleeding common, onset at puberty and worsens with ageLack of normal vascular smooth muscle, impairs ability to contractTreated with bipolar cautery or laser ablation, septodermoplasty, or nasal closure as a last resortUse of bevacizumab (Avastin), a VEGF inhibitor, increasing, currently under studyBlood dyscrasiasAlcoholism, malnutrition, malignancy, immunodeficiency, liver or kidney failureCharacterized by reduced platelet aggregation, prolonged bleeding time; treat with platelet transfusion for severe bleedsVon Willebrand diseaseDeficiency of von Willebrand protein leads to defective platelet adhesion and decreased activity of clotting factor VIII; treat with DDAVP, cryoprecipitate, or von Willebrand protein concentrate for severe bleedsHemophiliaDeficiency in clotting factor VIII (type A) or IX (type B); treat with factor VIII or IX concentrateDrugs (i.e., NSAIDs, Plavix, Coumadin)NSAIDs, ASA, and Plavix characterized by reduced platelet function; treat with platelet transfusionCoumadin inhibits formation of multiple clotting factors; reverse with Vitamin K and FFPManagement: Determine acuity and remember ABCs; ensure patient is stable and address any systemic disease or obvious associated comorbidityTopical vasoconstriction (e.g., oxymetazoline) and manual pressure for minor bleedsCauterization (silver nitrate, electric, or KTP/argon laser)Nasal packing can be anterior or posterior, ranging from a variety of nasal tampon devices to vaseline gauze packingAnterior packingRemoved after 2--5 days depending on severity and etiologyCan be managed as an outpatient unless patient is elderly or has underlying coagulopathy which requires treatmentComplications: toxic shock syndrome (give anti-staphylococcal antibiotic while packing in place), sinusitis from blockage of sinus ostia, septal necrosis/perforationPosterior packingOften requires sedation due to discomfortRequires inpatient stay to monitor airway; elderly or frail patients and those with underlying cardiopulmonary disease should be monitored in intensive care unit with low threshold for intubationComplications: airway compromise, nasal-vagal reflex (hypotension and bradycardia), alar necrosisGreater palatine foramen injection (local anesthetic 1 % lidocaine 1:100,000 epinephrine infiltrated into foramen---must aspirate prior to injection to ensure not in the vessel) helps control posterior bleedsSurgical evaluation with ligation of bleeding vessel(s)Internal maxillary artery (IMA): open posterior maxillary sinus wall, identify branches of IMA in pterygopalatine foramen and ligate with clipsSphenopalatine artery (SPA): endoscopically dissect in a subperiosteal plane along the medial inferior maxillary wall just anterior to lammellar attachment of middle turbinate, identify SPA as it exits at crista ethmoidalis and ligate with clip or cauterizeAnterior/posterior ethmoid arteries (AEA/PEA): can either identify endoscopically and cauterize with bipolar cautery within the nasal cavity or perform Lynch incision and dissect periorbita off medial orbital wall; AEA located 8--12 mm from lacrimal crest, PEA 10--12 mm from AEA, and optic nerve 4--6 mm from PEAAngiography and embolizationAngiography identifies site of active bleed, interventional radiologist performs embolization of specific branch or branches of external carotidComplications: Blindness (more common with internal carotid branches, and embolization of these branches would only be undertaken in a life saving procedure), necrosis, stroke, facial pain, paresthesia

Benign Masses/Abnormalities {#Sec8}
===========================

Nasopharyngeal cystsRathke's pouch cyst or craniopharyngiomaRemnant of ectodermal tissue precursor of anterior pituitary glandTx = reassurance versus endoscopic marsupialization if symptomaticTornwaldt cystRemnant of caudal notochordTx = reassurance versus endoscopic marsupialization if symptomaticMidline nasal massesArise as a result of failure of closure of anterior nasoporePersistence of fonticulus frontalis (opening between nasal and frontal bones in the embryo) allows for intracranial connection to prenasal spaceMRI = allows for assessment of intracranial extensionBiopsy of midline nasal mass in children contraindicated due to risk of IC extensionTx = open vs. endoscopic surgical excision, depending on whether or not external nasal structures involved.Glioma60 % Extranasal, 30 % intranasal, 10 % combined"Pinched off" glial tissue; can appear red and be confused with hemangiomaSymptoms = firm, nontender, noncompressible mass that does not transilluminate or change in sizeEncephalocele, meningocele, meningoencephaloceleHerniation of meninges (meningocele), meninges + brain (meningoencephalocele), or meninges + brain + part of ventricular system (meningoencephalocytocele) through skull base defectSac of glial tissue lined with ependymal cells25 % Anterior (sincipital/external versus basal/internal) and 75 % posterior, or occipital in locationSincipital/external: herniation occurs anterior to crista galli between frontal and ethmoid bones, presenting as external mass over nose or glabellaBasal/internal (less common): herniation occurs posterior to cribriform plate, presenting as an intranasal massSymptoms: soft, compressible mass that transilluminates and increases in size with crying (positive Furstenberg test)Dermoid CystSequestration of ectodermal and mesodermal elements anywhere along a tract extending from foramen cecum to nasal tipSymptoms = Fistulous tract, nasal pit with tuft of hairFibro-osseous lesions (*find also in Chap. 8*)Osteoma = most common benign sinonasal lesionFrontal sinus most commonGardner's syndrome = skull osteomas, colonic polyps, and soft tissue tumorsFibrous dysplasiaTwo types: Monostotic (most common, 70--80 %) and polyostoticMcCune-Albright Syndrome = polyostotic lesions, precocious puberty, pigmented skin lesionsCT findings: Early = radiolucent; Late = "ground-glass" + calcificationsTx = surgery only if symptomatic (debilitating pain or cosmetic deformity effecting quality of life), bisphosphonatesOssifying fibromaSolitary encapsulated slow growing monostotic tumorCT findings = central lucency with eggshell rimTx = surgery

Sinonasal Malignancy {#Sec9}
====================

See Head and Neck section

Surgical Approaches {#Sec10}
===================

Endoscopic approach (Functional endoscopic sinus surgery or FESS)Technique = Rigid nasal endoscopy +/− stereotactic image guidance, typical steps include medialization of middle turbinate, removal of uncinate process, maxillary antrostomy, ethmoidectomy, sphenoidotomy, and frontal recess exploration with sinosotomy as neededFour lamellae encountered (anterior → posterior) = uncinate process → ethmoid bulla → vertical portion of middle turbinate basal lamella → vertical portion of superior turbinate basal lamellaShould be considered for any lesion or disease process (congenital, inflammatory, neoplastic, traumatic, etc.) which can be accessed endoscopically, but the rhinologic surgeon must be familiar with open approaches for lesions which are inaccessible or incompletely addressed via this approachComplications = bleeding, synechiae, injury to the eye including blindness, CSF leak, nasolacrimal duct injury, brain injurySpecific endoscopic approaches to the frontal sinus:Draf I: complete removal of the anterior ethmoid cells and uncinate process within the frontal recess leading to the frontal ostium. Obstructing frontal cells, if present, are removed. The frontal sinus ostium may then drain into a patent frontal recess, but the frontal sinus ostium itself is not instrumented.Draf IIa: resecting all included in Draf I with the addition of widening the frontal sinus ostium itself, resecting all of the frontal sinus floor from lamina to the insertion of the middle turbinate mediallyDraf IIb: resecting all included in Draf IIa with the addition of resecting the middle turbinate up to skull base and widening the frontal sinus medially to the septumDraf III (aka Modified Lothrop): resecting all included in Draf II, with the addition of removing the intersinus septum and connecting bilateral frontal sinuses into one horseshoe-shaped sinus with a common drainage pathway

Open Approaches {#Sec11}
===============

Caldwell LucUsed most often to gain access to the anterior wall of the maxillary sinusPerformed through canine fossa with incision at gingivobuccal sulcusCan augment endoscopic surgery; good for anteriorly attached IP or other tumors, broader access to orbital floor and PPFComplications = cheek edema/ecchymosis, numbness or pain with infraorbital nerve injury, oroantral fistula, epiphora if damage to nasolacrimal ductExternal ethmoidectomyProvides access to ethmoid cavity, medial orbit, cribriform plate, and frontonasal area if endoscopy is not an option; can be employed to decompress subperiosteal abscessComplications = eye injury including blindness and corneal abrasions, CSF leak, skull base injury, bleeding from AEA +/− retraction of vessel into eyeExternal frontoethmoidectomy (Lynch procedure) or frontal trephineIndications: uncommonly used now, when endoscopic approach is for any reason insufficient to address frontoethmoid mucocele, mucopyocele, rhinosinusitis with orbital complications, frontoethmoid or anterior skull base tumor, CSF leak repair, acute sinusitis with intracranial or orbital complications or not responsive to medical management and unable to access endoscopically, lateral frontal mucoceleComplications = bleeding, epiphora, frontal sinusitis, diplopia, blindness, CSF leak, intracranial hemorrhageOsteoplastic flap with frontal sinus obliteration or cranializationIndications = when endoscopic approaches are insufficient or have failed to address osteomyelitis, frontal sinus tumor, recurrent persistent frontal sinusitis, trauma with comminuted anterior or posterior table fracturesOpen approaches to sphenoid sinus (historically used by neurosurgeons in pituitary surgery)Transseptal: incision can be endonasal, sublabial, or transcolumellarTransfacial incisionsLateral rhinotomy (incision made in naso-facial crease for small lesions of nasal cavity and medial maxilla), historically used for IP, no longer "gold standard"Weber-Ferguson (incision for lateral rhinotomy extended laterally in subciliary crease and inferiorly along philtrum through vermilion border to split lip, provides wide access for most sinonasal tumors)Craniofacial resectionBifrontal craniotomy with transfacial exposure of sinonasal cavity and orbits, allows for access to anterior cranial fossaUsed to approach skull base pathology including malignancy that cannot, for whatever reason, be accessed via the endoscopic approach

Major Complications of Sinus Surgery {#Sec12}
====================================

OrbitalIncludes blindness (direct injury or hematoma), penetration of orbit (may see fat herniation), diplopia (muscle injury), and epiphora (damage to lacrimal system)Retrobulbar hematoma is an acute complication which must be recognized immediately and treated to avoid blindnessCause = most commonly from venous injury near lamina papyracea or arterial injury to AEA during endoscopic surgery → retraction of vessel into orbit where pressure from hematoma compresses optic nerveSx = proptosis, chemosis, ecchymosis, vision change (if awake)Treatment = immediate ophthalmology consult, ice packs, mannitol, remove any nasal packing if it has been placed, surgical intervention (lateral canthotomy, +/− medial orbital wall decompression)Prevention = keep eyes visible during surgery and evaluate any imaging preoperatively to identify AEAs which run below skull baseCSF leakIf identified at the time of surgery the defect should be repaired at that time (most common site of iatrogenic injury = lateral lamella of ethmoid roof)If identified postoperatively (beta-2 transferrin positive thin watery rhinorrhea) can try conservative management first, although many surgeons would opt to go straight to surgery for repairConservative treatment = 7--10 days of bed rest, head elevation, stool softeners to avoid straining, lumbar drain for diversion (+/− antibiotics (prophylaxis for meningitis), no evidence to support use however most continue to use)Surgical repairIntracranial approach (50--70 % success rate) requires a coronal approach and carries risks of frontal lobe dysfunction, cerebral edema, seizures, and anosmiaExtracranial approach (80 % success rate) uses transfacial incisions, providing better visualization of the site of CSF leak but resulting in facial scarringEndoscopic endonasal approach (95 % success rate) has the least morbidityOverlay versus underlay repair (similar results) or both, using pedicled or free mucosal graft, pericranial flap, fat/fascia, synthetic dura are all options, with tissue glue/nasal packing per surgeon preferencePedicled nasoseptal flaps when performing an endoscopic repair have dramatically reduced rate of recurrent CSF leak in the literature
